Evidence map›Paper›PMID 31204101›Full record

ArticleCell2019

Fc Characteristics Mediate Selective Placental Transfer of IgG in HIV-Infected Women.

David R Martinez, Youyi Fong, Shuk Hang Li, Fang Yang, Madeleine F Jennewein, Joshua A Weiner, Erin A Harrell, Jesse F Mangold, Ria Goswami, George R Seage and 5 more

Abstract read
In one paragraph

Article in Cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Immune development in early life.Nature immunology · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Gut-X axis.iMeta · 2025
    Review
  19. Article
  20. Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

David R MartinezDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.
Youyi FongFred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Shuk Hang LiDuke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.
Fang YangDepartment of Molecular Biomedical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, NC 27607, USA.
Madeleine F JenneweinRagon Institute of the Massachusetts General Hospital, MIT and Harvard, Cambridge, MA 02139, USA.
Joshua A WeinerThayer School of Engineering, Dartmouth College, Hanover, NH 03755, USA.
Erin A HarrellDepartment of Molecular Biomedical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, NC 27607, USA.
Jesse F MangoldDuke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.
Ria GoswamiDuke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.
George R SeageDepartment of Epidemiology, Harvard T.H. School of Public Health, Boston, MA 02115, USA.
Galit AlterRagon Institute of the Massachusetts General Hospital, MIT and Harvard, Cambridge, MA 02139, USA.
Margaret E AckermanThayer School of Engineering, Dartmouth College, Hanover, NH 03755, USA.
Xinxia PengDepartment of Molecular Biomedical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, NC 27607, USA; Bioinformatics Graduate Program, North Carolina State University, Raleigh, NC 27607, USA; Bioinformatics Research Center, North Carolina State University, Raleigh, NC 27607, USA.
Genevieve G FoudaDuke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA; Department of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: genevieve.fouda@duke.edu.
Sallie R PermarDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA; Department of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: sallie.permar@duke.edu.

Funding

PHACS - Data and Operations CenterU01HD052102 · NICHD · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI WILLIAMS, PAIGE L · 2005 to 2019
$242.7M
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) GroupU01AI068632 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI JACKSON, J BROOKS · 2006 to 2010
$109.7M
Project 2: RNA vaccination in early life to induce potent and broad HIV Env-specific antibody responsesP01AI117915 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI DE PARIS, KRISTINA, PERMAR, SALLIE R. · 2015 to 2024
$21.2M
Pediatric HIV/AIDS Cohort Study (PHACS): Understanding Maternal HIV Disease through Pregnancy and the Postpartum Period and its Role in Child Health OutcomesU01HD052104 · NICHD · TULANE UNIVERSITY OF LOUISIANA · PI VAN DYKE, RUSSELL B. · 2005 to 2019
$15.7M
Transmission-blocking potential of novel HIV Env-specific mucosal antibodiesR01AI106380 · NIAID · DUKE UNIVERSITY · PI PERMAR, SALLIE R. · 2013 to 2017
$3.4M
Maternal immune protection against congenital CMV infectionDP2HD075699 · NICHD · DUKE UNIVERSITY · PI PERMAR, SALLIE R. · 2012 to 2017
$2.8M
Role of neutralizing antibodies in HIV-1-infected and vaccinated mothers in MTCTR01AI122909 · NIAID · DUKE UNIVERSITY · PI KUMAR, AMIT · 2016 to 2019
$2.6M
Statistical methods for HIV-1 immune correlates studiesR01AI122991 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI FONG, YOUYI · 2016 to 2020
$1.6M
FHCRC High-Performance Computing ClusterS10OD020069 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KOOPERBERG, CHARLES L · 2015 to 2015
$600k
Impact of Gastrointestinal Microbiome on the Host Response to an Effector-Memory T-Cell AIDS Vaccine and Multiple Low-Dose ChallengeR21AI120713 · NIAID · UNIVERSITY OF WASHINGTON · PI PENG, XINXIA · 2015 to 2016
$445k
Identifying cellular long non-coding RNAs as targets for HIV interventionR21AI125040 · NIAID · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI PENG, XINXIA · 2016 to 2017
$431k
Infant immune correlates of perinatal mother to child transmission of HIVR03HD085871 · NICHD · DUKE UNIVERSITY · PI FOUDA AMOU OU, GENEVIEVE GINY · 2015 to 2016
$158k
NIAID NIH HHS F31 AI127303NIAID NIH HHS P01 AI117915NIAID NIH HHS R01 AI106380NIAID NIH HHS R01 AI122909NIAID NIH HHS R01 AI122991NIAID NIH HHS R21 AI120713NIAID NIH HHS R21 AI125040NIAID NIH HHS U01 AI068632NICHD NIH HHS DP2 HD075699NICHD NIH HHS R03 HD085871NICHD NIH HHS U01 HD052102NICHD NIH HHS U01 HD052104NIH HHS S10 OD020069
6 · The paper itself

Abstract

The placental transfer of maternal IgG is critical for infant protection against infectious pathogens. However, factors that modulate the placental transfer of IgG remain largely undefined. HIV-infected women have impaired placental IgG transfer, presenting a unique "disruption model" to define factors that modulate placental IgG transfer. We measured the placental transfer efficiency of maternal HIV and pathogen-specific IgG in US and Malawian HIV-infected mothers and their HIV-exposed uninfected and infected infants. We examined the role of maternal HIV disease progression, infant factors, placental Fc receptor expression, IgG subclass, and glycan signatures and their association with placental IgG transfer efficiency. Maternal IgG characteristics, such as binding to placentally expressed Fc receptors FcγRIIa and FcγRIIIa, and Fc region glycan profiles were associated with placental IgG transfer efficiency. Our findings suggest that Fc region characteristics modulate the selective placental transfer of IgG, with implications for maternal vaccine design and infant health.

Indexed as

Infectious Disease Transmission, VerticalCohort StudiesDisease ProgressionFemaleGlycosylationHIVHIV InfectionsHumansImmunoglobulin Fc FragmentsImmunoglobulin GInfantInfant, NewbornMalawiPlacentaPregnancyPregnancy Complications, InfectiousFc gamma receptor IIAFCGR3A protein, humanImmunoglobulin Fc FragmentsImmunoglobulin GReceptors, IgGantibodiesHIVIgG Fc regioninfant protectionmaternal immunityplacental IgG transfer

Identifiers

PMID31204101
PMCPMC6727200

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.